The Biotech Growth Trust PLC
BIOG.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | £237,616 | £348,882 | £315,453 | £372,145 |
| - Cash | £8,453 | £2,131 | £2,772 | £0 |
| + Debt | £0 | £47,078 | £20,170 | £31,741 |
| Enterprise Value | £229,163 | £393,829 | £332,851 | £403,886 |
| Revenue | -£77,484 | £80,346 | -£37,654 | -£209,711 |
| % Growth | -196.4% | 313.4% | 82% | – |
| Gross Profit | -£78,809 | £77,999 | -£42,967 | -£214,513 |
| % Margin | 101.7% | 97.1% | 114.1% | 102.3% |
| EBITDA | -£82,516 | £0 | £0 | -£10,729 |
| % Margin | 106.5% | 0% | -0% | 5.1% |
| Net Income | -£82,661 | £74,600 | -£41,298 | -£202,419 |
| % Margin | 106.7% | 92.8% | 109.7% | 96.5% |
| EPS Diluted | -2.62 | 2.07 | -1.03 | -4.88 |
| % Growth | -226.6% | 301% | 78.9% | – |
| Operating Cash Flow | -£5,087 | -£4,241 | -£5,890 | -£12,141 |
| Capital Expenditures | £0 | £0 | £0 | -£1,045 |
| Free Cash Flow | -£5,087 | -£4,241 | -£5,890 | -£13,186 |